Stock Events

Stock Events

enVVeno Medical 

$10.42
24
+$0.04+0.39% Today

Statistics

Day High
10.9
Day Low
10.41
52W High
183.75
52W Low
8.67
Volume
14,833
Avg. Volume
-
Mkt Cap
210.65M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

30JulExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-10.5
-7.07
-3.65
-0.22
Expected EPS
-9.1
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-43.64MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NVNO. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap102.71B
Medtronic is a major player in the medical devices sector, offering products that can compete directly with enVVeno Medical's neurovascular and cardiovascular solutions.
Boston Scientific
BSX
Mkt Cap83.97B
Boston Scientific competes in the medical devices market, particularly in areas overlapping with enVVeno Medical's focus on neurovascular treatments.
Abbott Laboratories
ABT
Mkt Cap155.82B
Abbott Laboratories offers a wide range of medical devices, including those for cardiovascular and neuromodulation, making it a direct competitor.
Smith & Nephew
SNN
Mkt Cap13.3B
Smith & Nephew operates in the medical technology field, with products that could compete in the surgical sectors where enVVeno Medical may be involved.
Stryker
SYK
Mkt Cap112.88B
Stryker is known for its medical devices and equipment, competing in the neurotechnology and spine sector, which may overlap with enVVeno Medical's offerings.
Johnson & Johnson
JNJ
Mkt Cap546.9B
Johnson & Johnson, through its medical devices segment, competes across a broad range of healthcare products, including those that could be in direct competition with enVVeno Medical.
Zimmer Biomet
ZBH
Mkt Cap16.05B
Zimmer Biomet Holdings, Inc. competes in the musculoskeletal healthcare sector, which could include products and technologies competitive with enVVeno Medical's.
Edwards Lifesciences
EW
Mkt Cap48.42B
Edwards Lifesciences specializes in heart valves and hemodynamic monitoring, areas that could see overlap with enVVeno Medical's cardiovascular solutions.
Intuitive Surgical
ISRG
Mkt Cap162.13B
Intuitive Surgical, known for its da Vinci surgical systems, competes in the innovative surgical solutions space, potentially overlapping with enVVeno Medical's market.
Integra Lifesciences
IART
Mkt Cap830.03M
Integra LifeSciences, a provider of regenerative technologies, neurosurgical, and extremity orthopedic solutions, competes in areas that may overlap with enVVeno Medical's focus.

About

enVVeno Medical Corporation, a clinical-stage medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease. The company's lead product is the VenoValve, a replacement venous valve for the treatment of venous chronic venous insufficiency. Its VenoValve implanted into the femoral vein of the patient in an open surgical procedure via a 5-to-6-inch incision in the upper thigh. The company also develops enVVe, a non-surgical and transcatheter-based replacement venous valve system consisting of the enVVe valve, enVVe delivery system, and delivery system accessories. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.
Show more...
CEO
Mr. Robert A. Berman
Employees
37
Country
United States
ISIN
US29415J2050

Listings

STU
DE
5HJ0.STU
F
DE
5HJ0.F
XNAS
US
NVNO
BOATS
BOATS
NVNO.BOATS

0 Comments

Share your thoughts

FAQ

What is enVVeno Medical stock price today?▼
The current price of NVNO is $10.42 USD — it has increased by +0.39% in the past 24 hours. Watch enVVeno Medical stock price performance more closely on the chart.
What is enVVeno Medical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange enVVeno Medical stocks are traded under the ticker NVNO.
Is enVVeno Medical stock price growing?▼
NVNO stock has fallen by -1.68% compared to the previous week, the month change is a +0% rise, over the last year enVVeno Medical has showed a -91.38% decrease.
What is enVVeno Medical market cap?▼
Today enVVeno Medical has the market capitalization of 210.65M
When is the next enVVeno Medical earnings date?▼
enVVeno Medical is going to release the next earnings report on July 30, 2026.
What were enVVeno Medical earnings last quarter?▼
NVNO earnings for the last quarter are -6.05 USD per share, whereas the estimation was -0.28 USD resulting in a -2,060.71% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is enVVeno Medical revenue for the last year?▼
enVVeno Medical revenue for the last year amounts to 0 USD.
What is enVVeno Medical net income for the last year?▼
NVNO net income for the last year is -43.64M USD.
How many employees does enVVeno Medical have?▼
As of May 06, 2026, the company has 37 employees.
In which sector is enVVeno Medical located?▼
enVVeno Medical operates in the Health & Wellness sector.
When did enVVeno Medical complete a stock split?▼
The last stock split for enVVeno Medical was on January 20, 2026 with a ratio of 1:35.
Where is enVVeno Medical headquartered?▼
enVVeno Medical is headquartered in Irvine, United States.